The stock of Nkarta Inc (NKTX) has seen a 0.31% increase in the past week, with a -13.75% drop in the past month, and a -36.88% decrease in the past quarter. The volatility ratio for the week is 6.74%, and the volatility levels for the past 30 days are at 8.32% for NKTX. The simple moving average for the past 20 days is -11.72% for NKTX’s stock, with a -54.67% simple moving average for the past 200 days.
Is It Worth Investing in Nkarta Inc (NASDAQ: NKTX) Right Now?
NKTX has 36-month beta value of 0.88. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NKTX is 45.03M, and currently, short sellers hold a 23.14% ratio of that float. The average trading volume of NKTX on November 08, 2024 was 631.43K shares.
NKTX) stock’s latest price update
Nkarta Inc (NASDAQ: NKTX) has seen a decline in its stock price by -2.14 in relation to its previous close of 3.27. However, the company has experienced a 0.31% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-07 that SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today reported financial results for the third quarter ended September 30, 2024.
Analysts’ Opinion of NKTX
Many brokerage firms have already submitted their reports for NKTX stocks, with Rodman & Renshaw repeating the rating for NKTX by listing it as a “Buy.” The predicted price for NKTX in the upcoming period, according to Rodman & Renshaw is $14 based on the research report published on October 09, 2024 of the current year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see NKTX reach a price target of $16. The rating they have provided for NKTX stocks is “Strong Buy” according to the report published on August 14th, 2024.
Raymond James gave a rating of “Outperform” to NKTX, setting the target price at $16 in the report published on March 22nd of the current year.
NKTX Trading at -27.12% from the 50-Day Moving Average
After a stumble in the market that brought NKTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.30% of loss for the given period.
Volatility was left at 8.32%, however, over the last 30 days, the volatility rate increased by 6.74%, as shares sank -16.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.91% lower at present.
During the last 5 trading sessions, NKTX rose by +1.88%, which changed the moving average for the period of 200-days by -63.48% in comparison to the 20-day moving average, which settled at $3.63. In addition, Nkarta Inc saw -51.52% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NKTX starting from Hager Alicia J., who sale 3,396 shares at the price of $8.00 back on Jul 16 ’24. After this action, Hager Alicia J. now owns 103,819 shares of Nkarta Inc, valued at $27,168 using the latest closing price.
Trager James, the Chief Scientific Officer of Nkarta Inc, sale 456 shares at $5.60 during a trade that took place back on Jun 18 ’24, which means that Trager James is holding 150,959 shares at $2,554 based on the most recent closing price.
Stock Fundamentals for NKTX
Current profitability levels for the company are sitting at:
- -12.19 for the present operating margin
- 0.36 for the gross margin
The net margin for Nkarta Inc stands at -10.49. The total capital return value is set at -0.25. Equity return is now at value -27.99, with -21.95 for asset returns.
Based on Nkarta Inc (NKTX), the company’s capital structure generated 0.17 points at debt to capital in total, while cash flow to debt ratio is standing at -1.15. The debt to equity ratio resting at 0.2. The interest coverage ratio of the stock is -36.72.
Currently, EBITDA for the company is -120.48 million with net debt to EBITDA at -0.23. When we switch over and look at the enterprise to sales, we see a ratio of 23.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 15.91.
Conclusion
To put it simply, Nkarta Inc (NKTX) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
